Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Hennessy

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
The Journal of Rheumatology|July 3, 2013
Response of pediatric uveitis to tumor necrosis factor-α inhibitorsMelissa A Lerman, Jon M Burnham, Peter Y Chang, et al.
BMJ Open Diabetes Research & Care|September 8, 2017
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomesVincent Lo Re, Dena M Carbonari, M Elle Saine, et al.
Intensive Care Medicine|July 14, 2022
Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort studyTodd A Miano, Sean Hennessy, Wei Yang, et al.
Pharmacoepidemiology and Drug Safety|July 6, 2012
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studiesVincent Lo Re, Kevin Haynes, Eileen E Ming, et al.
BMJ Medicine|June 12, 2023
Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort studyVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
JAMA|August 16, 2022
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized PatientsVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
Pharmacoepidemiology and Drug Safety|June 27, 2013
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseVincent Lo Re, Kevin Haynes, David Goldberg, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
The Journal of Rheumatology|July 3, 2013
Response of pediatric uveitis to tumor necrosis factor-α inhibitorsMelissa A Lerman, Jon M Burnham, Peter Y Chang, et al.
BMJ Open Diabetes Research & Care|September 8, 2017
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomesVincent Lo Re, Dena M Carbonari, M Elle Saine, et al.
Intensive Care Medicine|July 14, 2022
Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort studyTodd A Miano, Sean Hennessy, Wei Yang, et al.
Pharmacoepidemiology and Drug Safety|July 6, 2012
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studiesVincent Lo Re, Kevin Haynes, Eileen E Ming, et al.
BMJ Medicine|June 12, 2023
Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort studyVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
JAMA|August 16, 2022
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized PatientsVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
Pharmacoepidemiology and Drug Safety|June 27, 2013
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseVincent Lo Re, Kevin Haynes, David Goldberg, et al.
Pageof 24